1. Allogeneic chondroprogenitors display immunosuppressive properties and are non-immunogenic in vitro. (April 2015) Authors: Lohan, P.; Treacy, O.; Lynch, K.; Griffin, M.; Ritter, T.; Ryan, A.E. Journal: Osteoarthritis and cartilage Issue: Volume 23(2015)Supplement 2 Page Start: A267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Culture expanded primary chondrocytes have potent immunomodulatory properties and do not induce an allogeneic immune response. Issue 3 (March 2016) Authors: Lohan, P.; Treacy, O.; Lynch, K.; Barry, F.; Murphy, M.; Griffin, M.D.; Ritter, T.; Ryan, A.E. Journal: Osteoarthritis and cartilage Issue: Volume 24:Issue 3(2016) Page Start: 521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Establishment of the in vivo immunological profile in collagenase induced osteoarthritis. (April 2018) Authors: Burke, A.J.; Mancuso, P.; Dooley, C.; Ritter, T.; Barry, F.; Murphy, M.J.; Ryan, A.E. Journal: Osteoarthritis and cartilage Issue: Volume 26(2018)Supplement 1 Page Start: S127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Mesenchymal stem cell therapy for osteoarthritis: how apoptotic cells modulate inflammation. (April 2018) Authors: Mancuso, P.; Burke, A.J.; Raman, S.; Ryan, A.E.; Ritter, T.; Barry, F.; Murphy, M.J. Journal: Osteoarthritis and cartilage Issue: Volume 26(2018)Supplement 1 Page Start: S297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗